Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission.
about
Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model.Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages.Cellulose Acetate Phthalate and Antiretroviral Nanoparticle Fabrications for HIV Pre-Exposure Prophylaxis
P2860
Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Tenofovir alafenamide and elvi ...... of HIV-1 vaginal transmission.
@en
type
label
Tenofovir alafenamide and elvi ...... of HIV-1 vaginal transmission.
@en
prefLabel
Tenofovir alafenamide and elvi ...... of HIV-1 vaginal transmission.
@en
P2093
P2860
P50
P1433
P1476
Tenofovir alafenamide and elvi ...... of HIV-1 vaginal transmission.
@en
P2093
Guobin Kang
Qingsheng Li
Wenjin Fan
P2860
P304
P356
10.1097/QAD.0000000000001349
P407
P577
2017-02-01T00:00:00Z